CMLD010509
Product Specifications
UNSPSC Description
CMLD010509 (SDS-1-021) is a highly specific inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1. CMLD010509 (SDS-1-021) shows an IC50 below 10 nM for most MM cell lines and induces apoptosis. CMLD010509 (SDS-1-021) is a potent and selective translation inhibitor through an eIF4E phosphorylation-independent mechanism[1].
Target Antigen
Apoptosis; c-Myc
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cmld010509.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H]([C@H]1C2=CC=CC=C2)[C@@H](O)[C@]3(O)[C@@]1(C4=CC=C(Br)C=C4)OC5=CC(OC)=CC(OC)=C35)NOC
Molecular Weight
556.40
References & Citations
[1]Manier S, et al. Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma. Sci Transl Med. 2017 May 10;9(389). pii: eaal2668.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-119271/CMLD010509-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-119271/
Clinical Information
No Development Reported
CAS Number
256497-58-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1112605-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae tRNA pseudouridine synthase A (truA)
Ask
View Details 
MBS1112605-02 0.1 mg (E-Coli)
Recombinant Streptococcus pneumoniae tRNA pseudouridine synthase A (truA)
Ask
View Details 
MBS1112605-03 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae tRNA pseudouridine synthase A (truA)
Ask
View Details MBS1112605-04 0.1 mg (Yeast)
Recombinant Streptococcus pneumoniae tRNA pseudouridine synthase A (truA)
Ask
View Details MBS1112605-05 0.02 mg (Baculovirus)
Recombinant Streptococcus pneumoniae tRNA pseudouridine synthase A (truA)
Ask
View Details